A surface characterization of barium sulfate particles in aqueous suspensio
ns was carried out in this work. With the aim of predicting the stability c
onditions of these widely used suspensions, the electrical surface properti
es of the particles were first studied by electrophoretic mobility determin
ations. It was found that both H+ and OH- ions can be considered as potenti
al-determining ions for the barium sulfate/water interface. The same conclu
sion was reached concerning the lattice ions, Ba2+ (mainly) and SO42-. It t
vas also found that increasing the concentration of sodium chloride in the
dispersion medium can even change the sign of the zeta (zeta) potential: it
is suggested that this behavior is an indirect effect provoked by changes
in the solubility of barium sulfate with the ionic strength. To compute the
van der Waals (LW) attraction between the particles as well as the acid-ba
se contribution to the total energy of interaction, a thermodynamic charact
erization of the interface was also carried out by measuring the rate of pe
netration of selected liquids through plugs of the particles. It was found
that barium sulfate particles are essentially monopolar in nature; that is,
they show electron-donor character as demonstrated by the essentially zero
value of the electron-acceptor component of their surface fi ee energy. Pr
etreatment of the particles with 10(-2) M solutions of BaCl2 and CaCl2 sign
ificantly reduced the electron-donor component, whereas both NaCl and Na2SO
4 provoked the opposite effect. This result is explained in terms of the ac
id-base character of the ions added. These data were used to calculate the
interaction energy between the particles. The effect of electrolyte concent
ration on rile stability of the suspensions was analyzed on the basis of th
e dependence with distance of the interaction energy between the particles.
Our results suggest that more stable suspensions of barium sulfate are pre
dicted if moderate amounts of SO42- ions are added to the dispersion medium
. (C) 2000 Wiley-Liss, Inc. and the American Pharmaceutical Association J P
harm Sci 89: 1134-1142, 2000.